Additive Port Caps
For Select Baxter and B.Braun IV Caps
SUPERIOR PROTECTION. SIMPLY.
Drug diversion concerns are driving the need to secure and protect a wide range of drug delivery devices. Prep-Lock™ Tamper Evident Additive Port Cap provides remarkable protection and protocol assurance to the mediation ports of compatible IV Bags, including Baxter, B.Braun, Fresenius Kabi, and more. The solid tamper-evident closure easily enhances medication safety, increases confidence in the integrity, and guards against tampering or misuse. The simply one-handed installation and considerable contribution to the integrity of IV Mediations have made these caps a favorite of pharmacists everywhere.
Deterrent to Diversion
Serves as an active deterrent to potential drug diversion and misuse
Through 50 years of service, IMI has become the standard for guarding Compounded Sterile Preparations.
DEA & USP
Tamper evident protocols may help your pharmacy comply with DEA and USP guidelines.
PROTECTION FOR YOUR IV BAG PREPARATIONS
Compounded sterile preparations (CSPs) are at their greatest risk when they leave the custody of your pharmacy. The Prep-Lock Tamper Evident Additive Port Cap greatly reduces the risk of your CSP being compromised either accidentally or intentionally. It ensures that product integrity is maintained from the time it leaves the sterile hood until it is administered by an authorized clinician. Pharmacist also greatly appreciate the additional visual indication of protocol adherence.
QUALITY AND SECURITY
The Simple, one-handed installation is pharmacists’ preferred method to providing tamper evident protection to IV Bag Preparations. The enclosed hinge and hidden lock design ensures that once the Cap is applied to the medication port, it cannot be removed without damaging the bag. Help ensure that your preparations arrive to patients without compromise.
“This is honestly the best cap we have ever purchased.”
The Staggering Cost of DiversionA recent study published in the Journal of Hospital Medicine cited the vast costs diversion poses for Health Systems. “Hospitals bear the cost of diverted drugs, internal investigations, and follow-up care for affected patients, and can...
To ensure safety throughout the supply chain and in the patient’s home, providers are adopting tamper-evident products for intravenous home infusion.
To better understand the steps home infusion providers are taking to ensure safety, Becker’s Hospital Review recently spoke with Neil Colby, RPh, an infusion pharmacist and Director of Infusion Pharmacy Services for CDRx Infusion
The Substance Abuse and Mental Health Services Administration and American Nurses Association estimate that 10% of health care workers experience substance abuse, given the access to medications in health care institutions. One report estimates that, in 2019, 148 million medication doses were diverted by health care employees.
Have questions about what a partnership with IMI can do for your organization? What more information on a product or pricing? Fill out the form below and one of our Specialists will get back to you as soon as possible (usually within one business day) or call the number to the right.
We offer complementary evaluatory samples.
You May Also Be Interested In
IMI remains at the forefront of developing new products specifically designed for the compounding industry. Our strategic partnerships with some of the biggest names in health care enable us to continusoulsy deliver the kind of high quality and high-value products that pharmacy operations demand. All IMI products are manufactured in the United States under the strictest quality standards at our FDA-registered, ISO 13485–certified facility. Browse our Comprehensive product families below, and as always our premium products are back with premium service. If you have any questions, contact us, we’re here to help!